Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews

No studies found 2 · 33.3%GRADE not reported 0 · 0%Very low 1 · 16.7%Low 2 · 33.3%Moderate 1 · 16.7%High 0 · 0%

Clinically important upper GI bleeding · people admitted to intensive care units

H2 receptor antagonists showed no clear difference in clinically important upper GI bleeding compared with antacids (low certainty).

1 finding from 1 review

Nosocomial pneumonia · people admitted to intensive care units

H2 receptor antagonists showed no clear difference in nosocomial pneumonia compared with antacids (low certainty).

1 finding from 1 review

ICU mortality · people admitted to intensive care units

It is very uncertain whether H2 receptor antagonists changes all‐cause mortality in ICU compared with antacids (very low certainty).

1 finding from 1 review

Duration of ICU stay · people admitted to intensive care units

The review found no eligible studies for this question.

1 finding from 1 review

Blood transfusion · people admitted to intensive care units

H2 receptor antagonists probably leads to higher number of participants requiring blood transfusion compared with antacids (moderate certainty).

1 finding from 1 review

Serious adverse events · people admitted to intensive care units

The review found no eligible studies for this question.

1 finding from 1 review